THE METABOLIC DISEASES OF THE MYOCARDIUM: THE IMPACT OF DIABETES AND OBESITY

Metabolic diseases such as diabetes mellitus and obesity have become major global health concerns due to their increasing prevalence and significant impact on cardiovascular health. This article explores the effects of these conditions on the myocardium, the muscular tissue of the heart. Diabetes leads to metabolic dysfunction in myocardial cells, promoting oxidative stress, inflammation, and eventual structural remodeling—a condition often referred to as diabetic cardiomyopathy. Similarly, obesity contributes to myocardial damage through lipid accumulation, insulin resistance, and chronic low-grade inflammation. These changes compromise cardiac function and increase the risk of heart failure and other cardiovascular complications. Understanding the molecular and cellular mechanisms behind these effects is crucial for early diagnosis, prevention, and the development of targeted therapeutic strategies. This paper emphasizes the importance of metabolic control in preserving myocardial health in patients with diabetes and obesity.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-10
DOI
https://doi.org/10.5281/zenodo.15628210
Primary Topic
Legal Systems and Judicial Processes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THE METABOLIC DISEASES OF THE MYOCARDIUM: THE IMPACT OF DIABETES AND OBESITY

Zenodo (CERN European Organization for Nuclear Research)
Legal Systems and Judicial Processes
article

THE METABOLIC DISEASES OF THE MYOCARDIUM: THE IMPACT OF DIABETES AND OBESITY

article en

Abstract

Metabolic diseases such as diabetes mellitus and obesity have become major global health concerns due to their increasing prevalence and significant impact on cardiovascular health. This article explores the effects of these conditions on the myocardium, the muscular tissue of the heart. Diabetes leads to metabolic dysfunction in myocardial cells, promoting oxidative stress, inflammation, and eventual structural remodeling—a condition often referred to as diabetic cardiomyopathy. Similarly, obesity contributes to myocardial damage through lipid accumulation, insulin resistance, and chronic low-grade inflammation. These changes compromise cardiac function and increase the risk of heart failure and other cardiovascular complications. Understanding the molecular and cellular mechanisms behind these effects is crucial for early diagnosis, prevention, and the development of targeted therapeutic strategies. This paper emphasizes the importance of metabolic control in preserving myocardial health in patients with diabetes and obesity.

Zenodo (CERN European Organization for Nuclear Research)
Samarkand State Medical Institute (UZ)
Good health and well-being
Openalex Percentile: Top 44%
Legal Systems and Judicial Processes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

THE METABOLIC DISEASES OF THE MYOCARDIUM: THE IMPACT OF DIABETES AND OBESITY · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS